EOLS
Evolus Inc
Price:  
4.64 
USD
Volume:  
1,596,874.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS Relative Valuation

-360.1%
Upside

As of 2026-03-22, the Relative Valuation of Evolus Inc (EOLS) is (12.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.64 USD, the upside of Evolus Inc based on Relative Valuation is -360.1%.

The range of the Relative Valuation is (8.43) - (12.48) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 10.6x - 17.3x 16.0x
Forward P/E multiples 9.6x - 15.7x 14.2x
Fair Price (8.43) - (12.48) (12.07)
Upside -281.7% - -368.9% -360.1%
4.64 USD
Stock Price
(12.07) USD
Fair Price

EOLS Relative Valuation - Historical P/E Data

Date P/E
2026-03-19 -5.94
2026-03-18 -6.06
2026-03-17 -6.16
2026-03-16 -6.33
2026-03-13 -6.29
2026-03-12 -6.16
2026-03-11 -6.77
2026-03-10 -6.63
2026-03-09 -6.72
2026-03-06 -6.94
2026-03-05 -7.10
2026-03-04 -7.02
2026-03-03 -5.18
2026-03-02 -5.38
2026-02-27 -5.40
2026-02-26 -5.64
2026-02-25 -5.65
2026-02-24 -5.40
2026-02-23 -5.44
2026-02-20 -5.49
2026-02-19 -5.55
2026-02-18 -5.45
2026-02-17 -5.51
2026-02-13 -5.40
2026-02-12 -5.37
2026-02-11 -5.40
2026-02-10 -5.59
2026-02-09 -5.32
2026-02-06 -5.65
2026-02-05 -5.54
2026-02-04 -5.76
2026-02-03 -5.90
2026-02-02 -6.16
2026-01-30 -5.89
2026-01-29 -5.85
2026-01-28 -6.02
2026-01-27 -6.21
2026-01-26 -6.05
2026-01-23 -6.18
2026-01-22 -6.38
2026-01-21 -6.15
2026-01-20 -6.35
2026-01-16 -6.53
2026-01-15 -6.28
2026-01-14 -6.30
2026-01-13 -7.18
2026-01-12 -7.24
2026-01-09 -7.09
2026-01-08 -7.20
2026-01-07 -7.10